Equillium Inc (NASDAQ:EQ) Reports Favorable Results From itolizumab Clinical Trials

Max - 0

INmune Bio Inc (NASDAQ:INMB) Releases Preliminary Data From XPro1595 Phase 1B...

Max - 0

Stoke Therapeutics Inc (NASDAQ:STOK) Announces The Publication Of Data Regarding Its...

Max - 0

Is Eco Innovation Group, Inc. (OTCMKTS:ECOX) an ESG Monster in the...

Max - 0

A Spoonful of Sugarmade Inc (OTCMKTS:SGMD)?

Max - 0

CHF Solutions Inc (NASDAQ:CHFS) Strikes Distribution Agreement Deal With RenalSense For...

Max - 0

NextCure Inc (NASDAQ:NXTC) Launches NC410’s Phase 1 And 2 Clinical Trials...

Max - 0

Fate Therapeutics Inc (NASDAQ:FATE) Gets FDA Approval On IND Application Of...

Max - 0

Moleculin Biotech Inc. (NASDAQ:MBRX) Enters Into an Agreement with Sterling Pharma...

Max - 0

Dynavax Technologies Corporation (NASDAQ:DVAX)’s Collaboration with Mount Sinai to Develop a...

Max - 0
1...212213214...248Page 213 of 248